ADAsorb Therapeutic Apheresis System from Medicap

In the past it was necessary to utilise different secondary devices for therapeutic-apheresis depending on the type of therapy and the needed adsorber.The groundbreaking innovation from medicap clinic consists in the developmentof a highly flexible system, which enables in just one secondary-device the application and the precise management of different adsorbers. At the same time - and this is yet another crucial advantage - ADAsorb® is compatible to various primary separation systems. This development makes ADAsorb® the worldwide first open secondary-system for different plasma adsorbers and thus has been encountered with great interest amongst experts. ADAsorb® simplifies the procedure significantly and reduces investment costs considerably. The diversity of treatmentoptions enables a high efficiency of the device, thus serving both the patient and the operator.

ADAsorb® – Overview Features and Advantages

  • Compact and highly flexible device.
  • Applicable for various indications.
  • Computer managed and monitored treatments.
  • Specially developed treatment software for every single
  • adsorber type.
  • Clearly structured menu: simple and intuitive handling
  • via touch screen monitor.
  • The operator is guided step by step through the treatment
  • with ADAsorb®.
  • Easy adjustment of therapy parameters for an optimal
  • adaption to each patient.
  • Text messages and information offer a clear support.
  • Information box: displays the data of all performed treatment cycles.
  • Treatment protocol can be saved
  • Graphical presentation of the extracorporeal ADAsorb® cycle ensures an overview any time.

Advantage Overview

Convincing innovative technology

First open apheresis system worldwide, which means variousadsorber types and technologies from differentmanufactures can be managed with ADAsorb®.

Flexibility, the way you want it

Application of different adsorbers and adsorber technologies.

Compatibility with diverse primary separation systems.

Efficiency that counts
 Only one apheresis system necessary.

  • reduced training time
  • reduced staff
  • reduced total costs

Following a range of established areas of application:

METABOLISM / LDL-Apheresis

  • Familial hypercholesterolemia
  • Elevated lipoprotein (a)
  • Defect apolipoprotein B-100

NEPHROLOGY

  • Goodpasture´s syndrome

RHEUMATOLOGY

  • Systemic lupus erythematosus (SLE)
  • Wegener´s granulomatosis
  • Rheumatoid arthritis

TRANSPLANTATION

  • HLA Hyperimmunisation
  • Acute Humoral Rejection (AHR)
  • AB0-incompatibility

CARDIOLOGY

  • Delated Cardiomyopathy (DCM)

HAEMATOLOGY

  • Acquired inhibitor against coagulation factor, i.e. Haemophilia with a factor VIII-Inhibitor
  • Thrombotic Thrombocytopenic Purpura (TTP)

NEUROLOGY

  • Guillain-Barré Syndrome (GBS)
  • Myasthenia Gravis (MG)

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.